NEXGEL, INC.
NXGL · XNASCIK 1468929fmd_0411104RHB3X10Y4G10MYPHBM6Manufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2018 to Jun 30, 2026, 34 periods
| Line item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Total revenues | 2 | 1 | 1 | 2 | 2 | 4 | 9 | 11 |
| Cost of revenue | 2 | 1 | 1 | 2 | 2 | 4 | 6 | 7 |
| Gross profit | 1 | (0) | (0) | 0 | 0 | 0 | 3 | 5 |
| Research and development | – | – | – | 0 | 0 | 0 | 0 | 0 |
| Selling, general and administrative | 2 | 2 | 2 | 3 | 3 | 4 | 6 | 8 |
| Total operating expenses | 2 | 2 | 2 | 3 | 4 | 4 | 6 | 8 |
| Operating income | (2) | (2) | (2) | (3) | (3) | (3) | (4) | (3) |
| Interest expense | – | – | – | – | 1 | 0 | 0 | 0 |
| Other non-operating income (expense) | – | 0 | (0) | (2) | (1) | 0 | 0 | 0 |
| Income before taxes | – | – | – | – | (5) | (3) | (3) | (3) |
| Income tax expense | – | 0 | 0 | 0 | 0 | – | – | – |
| Net income from continuing operations | – | – | – | – | (5) | – | – | – |
| Net income | (2) | (2) | (2) | (4) | (5) | (3) | (3) | (3) |